Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPz Cussons Regulatory News (PZC)

Share Price Information for Pz Cussons (PZC)

Share Price is delayed by 15 minutes
Get Live Data
87.40    2.10 (2.46%)
Bid:
87.00
Ask:
88.90
Spread: 1.90 (2.184%)
Market Cap: £367.39m
PZC Live PriceLast checked at - London Stock Exchange

Intraday Pz Cussons Share Chart

Interim Management Statement

23 Sep 2014 07:00

RNS Number : 3075S
PZ CUSSONS PLC
23 September 2014
 



23 September 2014

PZ Cussons Plc

(the "Group")

 

Interim Management Statement

 

PZ Cussons Plc, a leading international consumer products group, today issues the following interim management statement which covers the period 1 June 2014 to 22 September 2014, in advance of its Annual General Meeting, to be held at 10:30 today.

 

Overview of financial performance and position

 

The board is pleased to announce that the performance of the Group during the period has been in line with management expectations. The financial position of the Group remains strong with cash generation during the period also in line with management expectations.

 

Trading Update

 

Europe

 

In the UK, performance in the washing and bathing division has been strong despite challenging trading conditions, driven by an exciting innovation pipeline including the relaunch of the entire Imperial Leather range during the period.

 

The beauty division has performed well across its key markets of UK, US and Australia, with St Tropez's performance continuing to be boosted by Kate Moss as brand ambassador.

 

Performance in the smaller markets of Poland and Greece has been in line with expectations.

 

Asia

 

In Indonesia, good progress has been made in expanding the babycare portfolio as well as building non-babycare brands such as Original Source.

 

Performance in Australia has been good across the categories of Home Care, Personal Care, Beauty and Food & Nutrition. The acquisition of Australian food brand 5:AM, which completed in early August for £44.1m in cash, has shown pleasing performance to date with growth in line with expectations. The international expansion of Rafferty's Garden, acquired last year, will commence shortly with the launch of the range into the New Zealand market.

 

Trading in Thailand and the Middle East has also been in line with expectations.

 

Africa

 

In Nigeria, disruption in the north of the country has continued to worsen, resulting in a decline in sales in that region. Good growth has continued in the south of the country, in particular in the electrical goods business and in the two food and nutrition joint ventures. Whilst the impact of the West African Ebola outbreak has been relatively small in Nigeria, the situation is being carefully monitored.

 

In Ghana, performance has been affected by the continued weakening in the Cedi, whilst in Kenya performance has been in line with expectations.

 

 

Outlook

 

Whilst trading conditions in most markets remain challenging, the Group remains focussed on a dynamic and fast brand renovation and innovation programme, an ongoing cost reduction programme and successful delivery of new areas of growth such as Rafferty's Garden, Five:AM and the PZ Wilmar joint venture.

 

These initiatives will help to offset the continuing macro challenges, including foreign exchange and raw material volatility, and the reduction in profits from Poland as a result of last year's Home Care brands sale.

 

A further trading update will be made on 10 December 2014.

 

Enquiries:

 

PZ Cussons Plc

Brandon Leigh Tel: 0161 435 1236

 

Instinctif Partners

Zinka Bozovic Tel: 020 7457 2821 / 07769 255380

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
IMSQKBDQABKDDCB
Date   Source Headline
29th Jun 202311:06 amRNSDirector/PDMR Shareholding
27th Jun 20237:00 amRNSTrading Statement
21st Jun 20239:59 amRNSDirector/PDMR Shareholding
16th Jun 20237:00 amRNSDirectorate Change
19th May 20239:27 amRNSDirector/PDMR Shareholding
21st Apr 20239:00 amRNSIntention to Conduct Audit Tender
19th Apr 202310:01 amRNSDirector/PDMR Shareholding
13th Apr 20233:18 pmRNSHolding(s) in Company
13th Apr 20237:00 amRNSQ3 Trading Update
12th Apr 20232:18 pmRNSDirector/PDMR Shareholding
24th Mar 20237:00 amRNSDirectorate Change
21st Mar 20239:30 amRNSDirector/PDMR Shareholding
17th Mar 20234:35 pmRNSPrice Monitoring Extension
21st Feb 20239:31 amRNSDirector/PDMR Shareholding
8th Feb 20237:00 amRNS2023 Interim Results
19th Jan 20234:20 pmRNSDirector/PDMR Shareholding
20th Dec 20222:40 pmRNSDirector/PDMR Shareholding
2nd Dec 202212:55 pmRNSDirector/PDMR Shareholding
24th Nov 20223:24 pmRNSResult of AGM
24th Nov 20227:00 amRNSDirectorate Change
21st Nov 20223:21 pmRNSDirector/PDMR Shareholding
14th Nov 20227:00 amRNSNew Credit Facility Linked to B Corp Ambitions
18th Oct 20223:52 pmRNSDirector/PDMR Shareholding
14th Oct 20227:00 amRNSPublication of Annual Report and Notice of AGM
27th Sep 202210:52 amRNSDirector/PDMR Shareholding
23rd Sep 20223:04 pmRNSDirector/PDMR Shareholding
22nd Sep 20227:00 amRNS2022 Full Year Results
21st Sep 202210:06 amRNSDirector Declaration
2nd Sep 202210:29 amRNSHolding(s) in Company
19th Aug 202210:05 amRNSDirector/PDMR Shareholding
29th Jul 20229:46 amRNSDirector/PDMR Shareholding
20th Jul 20223:21 pmRNSDirector/PDMR Shareholding
27th Jun 20227:00 amRNSTrading update
21st Jun 20224:10 pmRNSDirector/PDMR Shareholding
20th May 202210:30 amRNSFurther re 2021 AGM voting results
19th May 20225:45 pmRNSDirector/PDMR Shareholding
21st Apr 202210:30 amRNSDirector/PDMR Shareholding
13th Apr 20227:00 amRNSTrading Statement
1st Apr 20229:00 amRNSDirector/PDMR Shareholding
25th Mar 202210:00 amRNSDirector/PDMR Shareholding
23rd Mar 20229:00 amRNSDirector/PDMR Shareholding
21st Mar 202210:15 amRNSDirector/PDMR Shareholding
21st Mar 20227:00 amRNSAcquisition of Childs Farm
21st Feb 202211:00 amRNSDirector/PDMR Shareholding
11th Feb 20229:25 amRNSDirector/PDMR Shareholding
11th Feb 20229:15 amRNSBoard update
9th Feb 20227:00 amRNSHalf-year Report
19th Jan 202210:10 amRNSDirector/PDMR Shareholding
20th Dec 20214:35 pmRNSDirector/PDMR Shareholding
9th Dec 20219:38 amRNSNotice of Interim Results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.